These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 21334976)

  • 1. Prospects for the gene therapy of spinal muscular atrophy.
    Passini MA; Cheng SH
    Trends Mol Med; 2011 May; 17(5):259-65. PubMed ID: 21334976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Molecular genetic basis of proximal spinal muscular atrophy and experience in its pharmaceutical treatment].
    Baranov VS; Kiselev AV; Vakharlovskiĭ VG; Zhelezniakova GIu; Komantsev VN; Malysheva OV; Glotov AS; Ivashchenko TE; Baranov AN
    Genetika; 2008 Oct; 44(10):1325-37. PubMed ID: 19062530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous scAAV9 delivery of a codon-optimized SMN1 sequence rescues SMA mice.
    Dominguez E; Marais T; Chatauret N; Benkhelifa-Ziyyat S; Duque S; Ravassard P; Carcenac R; Astord S; Pereira de Moura A; Voit T; Barkats M
    Hum Mol Genet; 2011 Feb; 20(4):681-93. PubMed ID: 21118896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spinal muscular atrophy: a deficiency in a ubiquitous protein; a motor neuron-specific disease.
    Monani UR
    Neuron; 2005 Dec; 48(6):885-96. PubMed ID: 16364894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spinal muscular atrophy: state-of-the-art and therapeutic perspectives.
    Wirth B
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2002 Jun; 3(2):87-95. PubMed ID: 12215230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spinal muscular atrophy: recent advances and future prospects.
    Nicole S; Diaz CC; Frugier T; Melki J
    Muscle Nerve; 2002 Jul; 26(1):4-13. PubMed ID: 12115944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SAHA ameliorates the SMA phenotype in two mouse models for spinal muscular atrophy.
    Riessland M; Ackermann B; Förster A; Jakubik M; Hauke J; Garbes L; Fritzsche I; Mende Y; Blumcke I; Hahnen E; Wirth B
    Hum Mol Genet; 2010 Apr; 19(8):1492-506. PubMed ID: 20097677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is RNA manipulation a viable therapy for spinal muscular atrophy?
    Horne C; Young PJ
    J Neurol Sci; 2009 Dec; 287(1-2):27-31. PubMed ID: 19758605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spinal muscular atrophy: from gene to therapy.
    Wirth B; Brichta L; Hahnen E
    Semin Pediatr Neurol; 2006 Jun; 13(2):121-31. PubMed ID: 17027862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CNS-targeted gene therapy improves survival and motor function in a mouse model of spinal muscular atrophy.
    Passini MA; Bu J; Roskelley EM; Richards AM; Sardi SP; O'Riordan CR; Klinger KW; Shihabuddin LS; Cheng SH
    J Clin Invest; 2010 Apr; 120(4):1253-64. PubMed ID: 20234094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spinal muscular atrophy: from animal model to clinical trial.
    Zanoteli E; Maximino JR; Conti Reed U; Chadi G
    Funct Neurol; 2010; 25(2):73-9. PubMed ID: 20923604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Molecular basis of spinal muscular atrophy: th SMN gene].
    Tizzano E; Baiget M
    Neurologia; 2000 Nov; 15(9):393-400. PubMed ID: 11195146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between severity and SMN protein level in spinal muscular atrophy.
    Lefebvre S; Burlet P; Liu Q; Bertrandy S; Clermont O; Munnich A; Dreyfuss G; Melki J
    Nat Genet; 1997 Jul; 16(3):265-9. PubMed ID: 9207792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of survival motor neuron expression in leukocytes and spinal cord in spinal muscular atrophy.
    Tsai LK; Yang CC; Ting CH; Su YN; Hwu WL; Li H
    J Pediatr; 2009 Feb; 154(2):303-5. PubMed ID: 19150680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An update of the mutation spectrum of the survival motor neuron gene (SMN1) in autosomal recessive spinal muscular atrophy (SMA).
    Wirth B
    Hum Mutat; 2000; 15(3):228-37. PubMed ID: 10679938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurodevelopmental consequences of Smn depletion in a mouse model of spinal muscular atrophy.
    Liu H; Shafey D; Moores JN; Kothary R
    J Neurosci Res; 2010 Jan; 88(1):111-22. PubMed ID: 19642194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spinal muscular atrophy: molecular genetics and diagnostics.
    Ogino S; Wilson RB
    Expert Rev Mol Diagn; 2004 Jan; 4(1):15-29. PubMed ID: 14711346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular analysis of the spinal muscular atrophy and neuronal apoptosis inhibitory protein genes in Saudi patients with spinal muscular atrophy.
    Al-Jumah M; Majumdar R; Al-Rajeh S; Awada A; Chaves-Carbello E; Salih M; Al-Shahwan S; Al-Subiey K; Al-Uthaim S
    Saudi Med J; 2003 Oct; 24(10):1052-4. PubMed ID: 14578966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic conversion of an SMN2 gene to SMN1: a novel approach to the treatment of spinal muscular atrophy.
    DiMatteo D; Callahan S; Kmiec EB
    Exp Cell Res; 2008 Feb; 314(4):878-86. PubMed ID: 18078930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival motor neuron SMN1 and SMN2 gene promoters: identical sequences and differential expression in neurons and non-neuronal cells.
    Boda B; Mas C; Giudicelli C; Nepote V; Guimiot F; Levacher B; Zvara A; Santha M; LeGall I; Simonneau M
    Eur J Hum Genet; 2004 Sep; 12(9):729-37. PubMed ID: 15162126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.